Oil drops amid rising stockpiles, demand concerns

Germany, France plan to suspend AstraZeneca Covid-19 vaccinations, deepening concerns about economic recovery


REUTERS March 16, 2021
PHOTO: PBRNEWS

LONDON:

Oil prices dropped on Tuesday, extending declines to three consecutive days, as rising stockpiles in the United States added to the risks to a demand recovery after countries including Germany and France halted Covid-19 vaccinations.

Brent crude was $1.03, or 1.5%, lower at $67.85 by 1002 GMT. US West Texas Intermediate (WTI) crude was down 96 cents, or 1.4%, at $64.43 a barrel.

Germany, France and Italy plan to suspend AstraZeneca Covid-19 injections after reports of possible serious side effects, although the World Health Organisation said there was no established link to the vaccine.

These moves are deepening concerns about a slow pace of vaccinations in the European Union, which may delay any economic recovery from the pandemic in one of the hardest-hit areas.

The pandemic eviscerated demand for oil but prices have recovered to levels seen before the global health crisis, only to be capped as vaccination rollouts have been slow in most countries.

In the United States, stockpiles are also rising because of last month’s “big freeze” which halted refining operations that have taken time to fully return.

“Short-term direction will be set by the weekly US inventory reports,” PVM analysts said in a note, adding the strength of the dollar against other currencies is weighing on oil prices.

The American Petroleum Institute, an industry group, will report crude stockpile levels later on Tuesday, followed by official numbers from the Department of Energy on Wednesday, with analysts expecting another week of gains.

Crude inventories increased by 12.8 million barrels in the week to March 5, against analysts’ expectations for a rise of less than one million barrels. 

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ

E-Publications

Most Read